The National Football League injury report, as provided by the league (OUT: Player will not play; DOUBTFUL: Player is unlikely to play; QUESTIONABLE: Player is not certain to play; DNP: did not ...

Center Cam Jurgens (back), wide receiver DeVonta Smith (hamstring) and left guard Landon Dickerson (knee) remained out of ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The Philadelphia Eagles opened the practice window for defensive end Brandon Graham and tight end C.J. Uzomah, and the Kansas ...

In addition to Graham, C.J. Uzomah (abdomen) also returned to practice after his window was opened on Thursday. He was placed ...

The latest declines in Eli Lilly's stock price occurred in response to management's presentation at the annual JPMorgan ...

We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Before The DeepSeek Sell-Off. In this article, we are ...

Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing lower-than-expected demand for its obesity ...

Eli Lilly CEO David Ricks joins 'Squawk on the Street' to discuss the company's drug pipeline, 2025 outlook, state of the weight loss drugs market, status of the weight loss drug pill, revised ...

Eli Lilly’s CEO Dave Ricks cited stocking levels and unexpected market dynamics in Q4 2024 in the GLP-1RA market.

Good afternoon, everybody. I'm Chris Schott at JPMorgan and it's my pleasure to be hosting this fireside chat today with Dave Ricks, Chairman and CEO of Eli Lilly. It's been a tremendous few years ...